Howard Hughes Medical Institute’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-95
Closed -$12K 493
2025
Q4
$12K Sell
95
-1
-1% -$130 0.01% 182
2025
Q3
$14K Hold
96
0.01% 155
2025
Q2
$15K Buy
+96
New +$15.2K 0.01% 147
2017
Q3
Sell
-53,101
Closed -$3.31M 126
2017
Q2
$3.31M Sell
53,101
-10,298
-16% -$608K 0.6% 42
2017
Q1
$3.38M Buy
63,399
+3,901
+7% +$211K 0.62% 39
2016
Q4
$3.19M Sell
59,498
-18,287
-24% -$930K 0.73% 35
2016
Q3
$4.05M Sell
77,785
-3,271
-4% -$166K 1.04% 26
2016
Q2
$3.85M Buy
81,056
+7,406
+10% +$350K 1.29% 27
2016
Q1
$3.27M Buy
+73,650
New +$3.13M 0.72% 34

Other funds holding ZTS

Howard Hughes Medical Institute's ZTS Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Zoetis (ZTS) in Q1 2026, closing a stake of 95 shares — an estimated $12K sold.

Howard Hughes Medical Institute first reported a position in ZTS in Q1 2016 and held it in 9 quarters. The position peaked at $4.05M in Q3 2016. 1,606 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Zoetis position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 95 Zoetis shares in Q1 2026, an estimated $12K.
  • Howard Hughes Medical Institute first reported a position in Zoetis in Q1 2016 and held it in 9 quarters.
  • Howard Hughes Medical Institute's Zoetis position peaked at $4.05M in Q3 2016.
  • 1,606 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.